| 1 |
Crovalimab
💬 | [1] Crovalimab Crovalimab | [1] CROVALIMAB CROVALIMAB | [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 48 48, 62, 109 💬
|
| 2 |
Eculizumab
💬 | [1] Eculizumab Eculizumab | [1] ECULIZUMAB ECULIZUMAB | [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [8] 11 11, 13, 14, 61, 62, 109, 221, 223 💬
|
| 3 |
Iptacopan
💬 | [1] Iptacopan Iptacopan | [1] Iptacopan Iptacopan | [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [8] 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 4 |
Iptacopan hydrochloride
💬 | [1] Iptacopan Iptacopan | [1] Iptacopan Iptacopan | [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [8] 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 5 |
Ravulizumab
💬 | [1] Ravulizumab Ravulizumab | [1] RAVULIZUMAB RAVULIZUMAB | [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [8] 2 2, 11, 13, 50, 62, 66, 109, 224 💬
|